Sidley Austin
Client SatisfactionRegularly collaborating with the firm’s US, China, and Singapore teams, Sidley Austin is recommended for its strong focus on private equity driven transactions within the life sciences and tech sectors. The group’s workload primarily consists of series financing, investment, and acquisition mandates. Practice head Raymond Oh maintains a broad practice spanning pre-IPO investments and PIPE transactions.
Testimonials
Collated independently by Legal 500 research team.
‘The continuity of the relationship is important so the the team understand our business needs. Raymond Oh and his team is quick to get on call and provide solutions in various agreements.’
‘Raymond Oh and his team are always able to offer multiple views of different stakeholders.’
‘They have a seamless team working across Singapore and Hong Kong on PE engagements. They did a good job in managing the complex DD and the documentation was also very complex.’
Key clients
- OnCusp Therapeutics, Inc.
- Medicxi
- Cellomics
- symplr software LLC
- Stonepeak Infrastructure Partners
- Blue InCube
Work highlights
- Represented OnCusp Therapeutics, Inc. in the oversubscribed US$100 million (more than RMB700 million) Series A financing round.
- Represented Cellomics in its Series B+ financing.
- Represented Medicxi in its US$40 million investment in D3 Bio, a biotechnology company based in China.
Practice head
The lawyer(s) leading their teams.
Raymond Oh